Evaluation of Comfort in Subjects With Moderate Dry Eye Disease
Not Applicable
Completed
- Conditions
- Dry Eye
- Registration Number
- NCT04830956
- Lead Sponsor
- Alcon Research
- Brief Summary
The purpose of this study is to evaluate the comfort of an ocular lubricant in dry eye subjects. This study will be conducted in Canada and Australia.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
- Able to understand and sign an information consent letter
- Willing and able to follow instructions and maintain the appointment schedule
- Has dry eye symptoms
Key
Exclusion Criteria
- Has suffered any ocular injury to either eye in the past 12 weeks
- Is pregnant or lactating at the time of enrollment
Other protocol-specified inclusion/exclusion criteria may apply.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Primary Outcome Measures
Name Time Method Change from baseline in comfort rating Baseline, up to 12 Hours (Day 1, each product) A visual analogue scale will be used
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie ocular lubricant efficacy in moderate dry eye disease?
How does the ocular lubricant in NCT04830956 compare to standard-of-care treatments for dry eye symptoms?
Are there specific biomarkers that correlate with improved comfort in dry eye patients using lubricants?
What adverse events are associated with long-term use of ocular lubricants in dry eye management?
What are the current combination therapies or competitor drugs for moderate dry eye disease treatment?
Trial Locations
- Locations (1)
Alcon Investigator 8169
🇦🇺Carlton, Victoria, Australia
Alcon Investigator 8169🇦🇺Carlton, Victoria, Australia